VIRCO BVBA
Patent Owner
Stats
- 10 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jun 23, 2016 most recent publication
Details
- 10 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 274 Total Citation Count
- Jul 24, 1998 Earliest Filing
- 20 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8945833 Method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of hepatitis C virus (HCV) for genotypes 1 to 6Oct 06, 09Feb 03, 15[C12Q]
8563236 Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistanceJan 13, 09Oct 22, 13[C12Q, C12P]
7977053 Circular probe amplification (CPA) using energy-transfer primersDec 12, 06Jul 12, 11[C07H, C12Q, C12P]
7494768 Mutational profiles in HIV-1 protease and reverse transcriptase correlated with phenotypic drug resistanceMay 30, 00Feb 24, 09[C12Q, C12P]
7058616 Method and system for predicting resistance of a disease to a therapeutic agent using a neural networkJun 08, 00Jun 06, 06[G06N]
6221578 Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strainsJul 24, 98Apr 24, 01[C07H, C12Q]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0177,407 METHOD FOR DETERMINING DRUG RESISTANCE MUTATIONS IN ANY OF THE NON-STRUCTURAL PROTEIN REGIONS NS3 TO NS5B OF HEPATITIS C VIRUS (HCV) FOR GENOTYPES 1 TO 6AbandonedDec 22, 14Jun 23, 16[C12Q, C07K]
2014/0025,310 METHOD FOR DETERMINING THE EFFICACY OF A COMBINATION THERAPYAbandonedSep 18, 13Jan 23, 14[G06F]
8574831 Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistanceExpiredNov 01, 07Nov 05, 13[C12Q]
2013/0079,506 METHOD FOR DESIGNING A DRUG REGIME FOR HIV-INFECTED PATIENTSAbandonedNov 05, 12Mar 28, 13[C07H]
2011/0146,387 Measurement system and method for determination and/or detection of one or more agents in one or more samples using said measurement systemAbandonedDec 16, 10Jun 23, 11[G01N]
2011/0020,831 GENETIC DETECTION OF HIV-1 STRAINS THAT USE THE CXCR4 CO-RECEPTORAbandonedMar 20, 09Jan 27, 11[C12Q]
7292944 Establishment of biological cut-off values for predicting resistance to therapyExpiredOct 22, 01Nov 06, 07[G06F]
2005/0064,397 Method for mutation detection in HIV-1 using pol sequencingAbandonedSep 08, 04Mar 24, 05[C12Q, C12P]
2004/0073,378 Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistanceAbandonedApr 16, 03Apr 15, 04[G01N, G06F]
2004/0067,511 Circular probe amplification (cpa) using energy-transfer primersAbandonedAug 22, 03Apr 08, 04[C12Q, C12P]
2003/0190,603 Method and system for predicting therapeutic agent resistance and for defining the genetic basis of drug resistance using neural networksAbandonedJun 02, 03Oct 09, 03[C12Q, G01N, G06F]
2003/0152,917 Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strainsAbandonedJan 15, 03Aug 14, 03[C12Q, C12N, G01N, G06F]
6528251 Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strainsExpiredDec 14, 00Mar 04, 03[C12Q]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
